Pterygium is one of the modern problems of ophthalmology. The exact etiology and pathogenesis of this disease has not been reliably established and, as a result, there is no universal method for its recurrence-free treatment. The literature data on various methods of pterygium surgical treatment such as 'bare sclera', conjunctival autograft, limbal stem cells transplantation techniques, amniotic membrane plasty and other methods was analyzed. The advantages and disadvantages of those surgery methods were identified. With consideration of the new data on proliferative nature of the disease, the results of adjuvant treatment of pterygium using cytostatics and anti-VEGF drugs were examined. Introduction of new technologies for the treatment of pterygium in practical health care can significantly improve the effectiveness of surgeries, reduce the incidence of postoperative complications and the number of relapses of the disease.

No abstract

The article presents an analysis of literature data on the changes in structure and frequency of eye injuries among the adult population of the Russian Federation over the recent years. An estimation of various socio-economic and medical factors influencing these indicators was derived. The article also reviews current methods of treatment of eye injuries, and provides an evaluation of their effectiveness.

No abstract

Stillavit can be recommended as the drug of choice for patients after surgical treatment of pterygium. Components of the preparation (0.16% sodium hyaluronate, 0.05% sodium chondroitin sulfate, and 1% dexapanthenolum) act on each of the links in the pathogenesis of recurrent pterygium - slow epithelialization of the cornea, associated inflammation and formation of dry areas of the cornea.